Immunomedics to Present at Upcoming Healthcare Conferences – MarketWatch (press release)
Immunomedics to Present at Upcoming Healthcare Conferences MarketWatch (press release) We have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or "naked" form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins, ... |
Antibodies, not hard bodies: The real reason women drool over Brad Pitt – Fox News
 Mother Nature Network | Antibodies, not hard bodies: The real reason women drool over Brad Pitt Fox News The vaccine triggers the immune system to create antibodies against the virus. The researchers measured these levels of antibodies as well as testosterone levels and levels of the stress hormone cortisol. Next, 94 Latvian women, also in their early 20s ... Women are attracted to men with healthy faces |
New microfluidic device could be used to diagnose and monitor cancer and other … – PhysOrg.com
 PhysOrg.com | New microfluidic device could be used to diagnose and monitor cancer and other ... PhysOrg.com A more specific way to isolate cells is to use antibodies that latch on to distinctive molecules displayed on the surfaces of the target cells. However, this selective approach only works if the target cells come into contact with the antibodies ... |
‘DNA Origami’ nanorobots hunt and kill cancer cells – GMA News
 Technorati | 'DNA Origami' nanorobots hunt and kill cancer cells GMA News The nanorobots can transport payloads such as drug molecules and antibodies to specific cells of the body, tech site Technorati reported. "We can finally integrate sensing and logical computing functions via complex, yet predictable, ... “DNA Nanorobots” Have Successfully Been Used for Cancer Treatment Nanobots Seek and Destroy Cancer Cells 'DNA robots' target and kill cancer cells |
NICE recommends earlier use of Roche’s RoActemra for rheumatoid arthritis – PMLiVE
 USA TODAY | NICE recommends earlier use of Roche's RoActemra for rheumatoid arthritis PMLiVE ... for people with RA as a third-line treatment option if DMARDs had been ineffective, and if patients had also both demonstrated an inadequate response to one or more TNF inhibitors and could not take another Roche drug, MabThera (rituximab). Green light for earlier use of rheumatoid arthritis drug |
Xencor, Boehringer Ingelheim partner to develop and supply biosuperior … – News-Medical.net
 OutSourcing-Pharma.com | Xencor, Boehringer Ingelheim partner to develop and supply biosuperior ... News-Medical.net Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ... Xencor, Boehringer collaborate to develop biosuperior monoclonal antibodies Boehringer Ingelheim and Xencor Enter a Collaboration Agreement for the ... Boehringer Ingelheim and Xencor announce new collaboration |
Pharma industry’s pre budget memorandum seeks duty cuts, incentives from FM – pharmabiz.com
Pharma industry's pre budget memorandum seeks duty cuts, incentives from FM pharmabiz.com Leading industry body FICCI has called for exemption of duty for antigens, antibodies used in diagnostic kits. “The import of raw materials such as antigens/antibodies or any other ingredient corresponding to the manufacture of diagnostic test kits ... |
New vaccine is effective against all major strains of hepatitis C – Gizmag
 Gizmag | New vaccine is effective against all major strains of hepatitis C Gizmag Continuing work started more than 10 years ago at drug company Novartis, Houghton and co-investigator in his University of Alberta lab, John Law, have found that recipients of their vaccine produce antibodies that could neutralize hepatitis C. Vaccine Discovered For hep C |
Ensuring Animal Welfare: Aves Labs Re-Accredited by AAALAC International – Seattle Post Intelligencer
Ensuring Animal Welfare: Aves Labs Re-Accredited by AAALAC International Seattle Post Intelligencer Aves Labs, a custom antibodies company specializing exclusively in the production of chicken polyclonal antibodies, has once again received full re-accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care ... |
Pixantrone Progresses Toward Approval in the European Union – Medscape
Pixantrone Progresses Toward Approval in the European Union Medscape In addition, the CHMP noted that the benefit of pixantrone appeared to be lower in patients who had used rituximab in the past, and that its benefit was not established when used as a fifth round of chemotherapy, or later, in patients whose disease did ... |